Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Valvular Heart Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 93 articles:
HTML format



Single Articles


    January 2022
  1. LEE JM, Park HB, Song JE, Kim IC, et al
    The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0259638.
    PubMed     Abstract available


  2. TONNESSEN TC, Melleby AO, Hauge-Iversen IM, Espe EKS, et al
    Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice.
    PLoS One. 2022;17:e0262821.
    PubMed     Abstract available


  3. HULTKVIST H, Nylander E, Tamas E, Svedjeholm R, et al
    Evaluation of left ventricular diastolic function in patients operated for aortic stenosis.
    PLoS One. 2022;17:e0263824.
    PubMed     Abstract available


  4. LEE HJ, Kim HK, Lee SC, Ommen SR, et al
    Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0264580.
    PubMed     Abstract available


  5. ZHANG C, Liu J, Qin S
    Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263378.
    PubMed     Abstract available


  6. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
    Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
    PLoS One. 2022;17:e0266939.
    PubMed     Abstract available


  7. VICENZI M, Caravita S, Rota I, Casella R, et al
    The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
    PLoS One. 2022;17:e0265059.
    PubMed     Abstract available


  8. GROUND M, Waqanivavalagi S, Park YE, Callon K, et al
    Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells.
    PLoS One. 2022;17:e0270227.
    PubMed     Abstract available


  9. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    PubMed     Abstract available


  10. SALEH QW, Diederichsen ACP, Lindholt JS
    Individualized prediction of risk of ascending aortic syndromes.
    PLoS One. 2022;17:e0270585.
    PubMed     Abstract available


  11. BAGARDI M, Ghilardi S, Zamarian V, Ceciliani F, et al
    Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
    PLoS One. 2022;17:e0266208.
    PubMed     Abstract available


  12. STROM JB, Playford D, Stewart S, Li S, et al
    Increasing risk of mortality across the spectrum of aortic stenosis is independent of comorbidity & treatment: An international, parallel cohort study of 248,464 patients.
    PLoS One. 2022;17:e0268580.
    PubMed     Abstract available


  13. BOUWMEESTER S, van Loon T, Ploeg M, Mast TP, et al
    Left atrial remodeling in mitral regurgitation: A combined experimental-computational study.
    PLoS One. 2022;17:e0271588.
    PubMed     Abstract available


  14. COL NF, Otero D, Lindman BR, Horne A, et al
    What matters most to patients with severe aortic stenosis when choosing treatment? Framing the conversation for shared decision making.
    PLoS One. 2022;17:e0270209.
    PubMed     Abstract available


  15. SAIJO Y, Wang TKM, Chan N, Sperry BW, et al
    Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle.
    PLoS One. 2022;17:e0273419.
    PubMed     Abstract available


  16. BORJESSON E, Svennblad B, Wisten A, Borjesson M, et al
    Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden.
    PLoS One. 2022;17:e0273567.
    PubMed     Abstract available


    January 2021
  17. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed     Abstract available


  18. TAYAL B, Malahfji M, Buergler JM, Shah DJ, et al
    Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study.
    PLoS One. 2021;16:e0245934.
    PubMed     Abstract available


  19. WIENER PC, Darwish A, Friend E, Kadem L, et al
    Energy loss associated with in-vitro modeling of mitral annular calcification.
    PLoS One. 2021;16:e0246701.
    PubMed     Abstract available


  20. RADBILL AE, Lei LY, Paranjape SY, Blackwell DJ, et al
    Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0246768.
    PubMed     Abstract available


  21. TANIGUCHI Y, Sakakura K, Nomura Y, Hatori M, et al
    Comparison of long-term outcomes after trans-catheter aortic valve implantation between patients primarily diagnosed by cardiac murmur and those diagnosed by other reasons.
    PLoS One. 2021;16:e0247588.
    PubMed     Abstract available


  22. GODLEWSKI K, Dryzek P, Sadurska E, Werner B, et al
    Left ventricular systolic function impairment in children after balloon valvuloplasty for congenital aortic stenosis assessed by 2D speckle tracking echocardiography.
    PLoS One. 2021;16:e0248862.
    PubMed     Abstract available


  23. KVASLERUD AB, Santic K, Hussain AI, Auensen A, et al
    Outcomes in asymptomatic, severe aortic stenosis.
    PLoS One. 2021;16:e0249610.
    PubMed     Abstract available


  24. PETRYKA-MAZURKIEWICZ J, Ziolkowska L, Mazurkiewicz L, Kowalczyk-Domagala M, et al
    Right-ventricular mechanics assessed by cardiovascular magnetic resonance feature tracking in children with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0248725.
    PubMed     Abstract available


  25. HAMMER Y, Talmor-Barkan Y, Abelow A, Orvin K, et al
    Myocardial extracellular volume quantification by computed tomography predicts outcomes in patients with severe aortic stenosis.
    PLoS One. 2021;16:e0248306.
    PubMed     Abstract available


  26. ROY D, Mazumder O, Sinha A, Khandelwal S, et al
    Multimodal cardiovascular model for hemodynamic analysis: Simulation study on mitral valve disorders.
    PLoS One. 2021;16:e0247921.
    PubMed     Abstract available


  27. CHOUAIRI F, Mullan CW, Sen S, Mori M, et al
    Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.
    PLoS One. 2021;16:e0247789.
    PubMed     Abstract available


  28. KUSNER J, Luraghi G, Khodaee F, Rodriguez Matas JF, et al
    Understanding TAVR device expansion as it relates to morphology of the bicuspid aortic valve: A simulation study.
    PLoS One. 2021;16:e0251579.
    PubMed     Abstract available


  29. WILLITS I, Keltie K, de Belder M, Henderson R, et al
    Safety, effectiveness and costs of percutaneous mitral valve repair: A real-world prospective study.
    PLoS One. 2021;16:e0251463.
    PubMed     Abstract available


  30. LEMES DA SILVA MV, Nunes Filho ACB, Rosa VEE, Caixeta A, et al
    Improvement of renal function after transcatheter aortic valve replacement in patients with chronic kidney disease.
    PLoS One. 2021;16:e0251066.
    PubMed     Abstract available


  31. AYME-DIETRICH E, Da Silva S, Bouabout GA, Arnoux A, et al
    Characterization of the spontaneous degenerative mitral valve disease in FVB mice.
    PLoS One. 2021;16:e0257022.
    PubMed     Abstract available


  32. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    PubMed     Abstract available


  33. LIAW J, Walker B, Hall L, Gorton S, et al
    Rheumatic heart disease in pregnancy and neonatal outcomes: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253581.
    PubMed     Abstract available


  34. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    PubMed     Abstract available


  35. RIENGVIRODKIJ N, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS.
    PLoS One. 2021;16:e0255611.
    PubMed     Abstract available


  36. ABU KHADIJA H, Gandelman G, Ayyad O, Jaber M, et al
    Differential systemic inflammatory responses after TAVI: The role of self versus balloon expandable devices.
    PLoS One. 2021;16:e0258963.
    PubMed     Abstract available


  37. YAMAWAKI M, Honda Y, Makino K, Nakano T, et al
    Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access.
    PLoS One. 2021;16:e0260385.
    PubMed     Abstract available


  38. DA SILVA TL JR, Pazin-Filho A, Romano MMD, Ferriani VPL, et al
    Mitral valve thickening in acute rheumatic fever as a predictor of late valvar dysfunction.
    PLoS One. 2021;16:e0259737.
    PubMed     Abstract available


    January 2020
  39. SEMAKULA JR, Mouton JP, Jorgensen A, Hutchinson C, et al
    A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    PLoS One. 2020;15:e0227458.
    PubMed     Abstract available


  40. KIM D, Shim CY, Hong GR, Jeong H, et al
    Morphological and functional characteristics of mitral annular calcification and their relationship to stroke.
    PLoS One. 2020;15:e0227753.
    PubMed     Abstract available


  41. GUGLIELMINI C, Toaldo MB, Chiesa A, Contiero B, et al
    Effect of temperature variation on hospital admissions and outcomes in dogs with myxomatous mitral valve disease and new onset pulmonary edema.
    PLoS One. 2020;15:e0227807.
    PubMed     Abstract available


  42. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    PubMed     Abstract available


  43. VENNEMANN B, Obrist D, Rosgen T
    A smartphone-enabled wireless and batteryless implantable blood flow sensor for remote monitoring of prosthetic heart valve function.
    PLoS One. 2020;15:e0227372.
    PubMed     Abstract available


  44. MIURA S, Inoue K, Kumamaru H, Yamashita T, et al
    Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement.
    PLoS One. 2020;15:e0229721.
    PubMed     Abstract available


  45. OWASHI KP, Hubert A, Galli E, Donal E, et al
    Model-based estimation of left ventricular pressure and myocardial work in aortic stenosis.
    PLoS One. 2020;15:e0229609.
    PubMed     Abstract available


  46. XU L, Chen X, Cui M, Ren C, et al
    The improvement of the shear stress and oscillatory shear index of coronary arteries during Enhanced External Counterpulsation in patients with coronary heart disease.
    PLoS One. 2020;15:e0230144.
    PubMed     Abstract available


  47. PALUMBO MC, Rong LQ, Kim J, Navid P, et al
    Prosthetic aortic graft replacement of the ascending thoracic aorta alters biomechanics of the native descending aorta as assessed by transthoracic echocardiography.
    PLoS One. 2020;15:e0230208.
    PubMed     Abstract available


  48. HABERMAN D, Chernin G, Meledin V, Zikry M, et al
    Urea level is an independent predictor of mortality in patients with severe aortic valve stenosis.
    PLoS One. 2020;15:e0230002.
    PubMed     Abstract available


  49. HARDT F, Becker M, Brandenburg V, Grebe J, et al
    Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis.
    PLoS One. 2020;15:e0229636.
    PubMed     Abstract available


  50. GITTENBERGER-DE GROOT AC, Peterson JC, Wisse LJ, Roest AAW, et al
    Pulmonary ductal coarctation and left pulmonary artery interruption; pathology and role of neural crest and second heart field during development.
    PLoS One. 2020;15:e0228478.
    PubMed     Abstract available


  51. PAULUS MG, Meindl C, Bohm L, Holzapfel M, et al
    Predictors of functional improvement in the short term after MitraClip implantation in patients with secondary mitral regurgitation.
    PLoS One. 2020;15:e0232817.
    PubMed     Abstract available


  52. LARUPA SANTOS J, Rodriguez I, S Olesen M, Hjorth Bentzen B, et al
    Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation.
    PLoS One. 2020;15:e0232719.
    PubMed     Abstract available


  53. NIJENKAMP LLAM, Bollen IAE, Niessen HWM, Dos Remedios CG, et al
    Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy.
    PLoS One. 2020;15:e0232427.
    PubMed     Abstract available


  54. EL-REWAIDY H, Neisius U, Nakamori S, Ngo L, et al
    Characterization of interstitial diffuse fibrosis patterns using texture analysis of myocardial native T1 mapping.
    PLoS One. 2020;15:e0233694.
    PubMed     Abstract available


  55. LI Q, Laflamme DP, Bauer JE
    Serum untargeted metabolomic changes in response to diet intervention in dogs with preclinical myxomatous mitral valve disease.
    PLoS One. 2020;15:e0234404.
    PubMed     Abstract available


  56. SEO J, Kim DY, Cho I, Hong GR, et al
    Prevalence, predictors, and prognosis of tricuspid regurgitation following permanent pacemaker implantation.
    PLoS One. 2020;15:e0235230.
    PubMed     Abstract available


  57. BRAMBILLA PG, Polli M, Pradelli D, Papa M, et al
    Epidemiological study of congenital heart diseases in dogs: Prevalence, popularity, and volatility throughout twenty years of clinical practice.
    PLoS One. 2020;15:e0230160.
    PubMed     Abstract available


  58. OZTURK C, Becher MU, Kalkan A, Kavsur R, et al
    The modified MIDA-Score predicts mid-term outcomes after interventional therapy of functional mitral regurgitation.
    PLoS One. 2020;15:e0236265.
    PubMed     Abstract available


  59. CHANG MC, Wu MT, Weng KP, Chien KJ, et al
    Biventricular myocardial adaptation in patients with repaired tetralogy of Fallot: Mechanistic insights from magnetic resonance imaging tissue phase mapping.
    PLoS One. 2020;15:e0237193.
    PubMed     Abstract available


  60. TRINDADE F, Saraiva F, Keane S, Leite-Moreira A, et al
    Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy.
    PLoS One. 2020;15:e0237000.
    PubMed     Abstract available


  61. FEUILLATRE H, Auffret V, Castro M, Lalys F, et al
    Similarity measures and attribute selection for case-based reasoning in transcatheter aortic valve implantation.
    PLoS One. 2020;15:e0238463.
    PubMed     Abstract available


  62. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    PubMed     Abstract available


  63. JAAKKOLA J, Jaakkola S, Airaksinen KEJ, Husso A, et al
    Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    PLoS One. 2020;15:e0238953.
    PubMed     Abstract available


  64. AL-SHAMMARI H, Latif N, Sarathchandra P, McCormack A, et al
    Expression and function of mechanosensitive ion channels in human valve interstitial cells.
    PLoS One. 2020;15:e0240532.
    PubMed     Abstract available


  65. OKAMOTO R, Goto I, Nishimura Y, Kobayashi I, et al
    Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish.
    PLoS One. 2020;15:e0240129.
    PubMed     Abstract available


  66. PEVERILL RE, Chou B, Donelan L, Thai WE, et al
    Left ventricular long-axis function in hypertrophic cardiomyopathy - Relationships between e`, early diastolic excursion and duration, and systolic excursion.
    PLoS One. 2020;15:e0240296.
    PubMed     Abstract available


  67. JOLL JE 2ND, Clark CR, Peters CS, Raddatz MA, et al
    Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
    PLoS One. 2020;15:e0238407.
    PubMed     Abstract available


  68. AL HAGEH C, Rahy R, Khazen G, Brial F, et al
    Plasma and urine metabolomic analyses in aortic valve stenosis reveal shared and biofluid-specific changes in metabolite levels.
    PLoS One. 2020;15:e0242019.
    PubMed     Abstract available


  69. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    PubMed     Abstract available


  70. MINO T, Kimura S, Kitaura A, Iwamoto T, et al
    Can left ventricular hypertrophy on electrocardiography detect severe aortic valve stenosis?
    PLoS One. 2020;15:e0241591.
    PubMed     Abstract available


  71. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available


    January 2019
  72. MAYR NP, Wiesner G, Kretschmer A, Bronner J, et al
    Assessing the level of radiation experienced by anesthesiologists during transfemoral Transcatheter Aortic Valve Implantation and protection by a lead cap.
    PLoS One. 2019;14:e0210872.
    PubMed     Abstract available


  73. CZIMBALMOS C, Csecs I, Toth A, Kiss O, et al
    The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.
    PLoS One. 2019;14:e0211624.
    PubMed     Abstract available


  74. SUNG SH, Lee CW, Wang PN, Lee HY, et al
    Cognitive functions and jugular venous reflux in severe mitral regurgitation: A pilot study.
    PLoS One. 2019;14:e0207832.
    PubMed     Abstract available


  75. NOMURA K, Ajiro Y, Nakano S, Matsushima M, et al
    Characteristics of mitral valve leaflet length in patients with pectus excavatum: A single center cross-sectional study.
    PLoS One. 2019;14:e0212165.
    PubMed     Abstract available


  76. ZHAO M, Liu M, Leal JP, Tsui BMW, et al
    Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy.
    PLoS One. 2019;14:e0212573.
    PubMed     Abstract available


  77. STEINMETZ M, Schmitter C, Radecke T, Stundl A, et al
    Brief report - Telomere length is a poor biomarker to predict 1-year mortality or cardiovascular comorbidity in patients with transcatheter aortic valve replacement.
    PLoS One. 2019;14:e0213250.
    PubMed     Abstract available


  78. KNY M, Csalyi KD, Klaeske K, Busch K, et al
    Ninjurin1 regulates striated muscle growth and differentiation.
    PLoS One. 2019;14:e0216987.
    PubMed     Abstract available


  79. MILLER RJH, Heidary S, Pavlovic A, Schlachter A, et al
    Defining genotype-phenotype relationships in patients with hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging.
    PLoS One. 2019;14:e0217612.
    PubMed     Abstract available


  80. STUNDL A, Lucht H, Shamekhi J, Weber M, et al
    Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
    PLoS One. 2019;14:e0217544.
    PubMed     Abstract available


  81. CHRISTENSEN NL, Dahl JS, Carter-Storch R, Jensen K, et al
    Association between left ventricular diastolic function and right ventricular function and morphology in asymptomatic aortic stenosis.
    PLoS One. 2019;14:e0215364.
    PubMed     Abstract available


  82. DE LANGE MMA, Scheepmaker A, van der Hoek W, Leclercq M, et al
    Risk of chronic Q fever in patients with cardiac valvulopathy, seven years after a large epidemic in the Netherlands.
    PLoS One. 2019;14:e0221247.
    PubMed     Abstract available


  83. NEISIUS U, Myerson L, Fahmy AS, Nakamori S, et al
    Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    PLoS One. 2019;14:e0221061.
    PubMed     Abstract available


  84. TAN K, Markby G, Muirhead R, Blake R, et al
    Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
    PLoS One. 2019;14:e0221126.
    PubMed     Abstract available


  85. ZHANG Y, Wang VY, Morgan AE, Kim J, et al
    Mechanical effects of MitraClip on leaflet stress and myocardial strain in functional mitral regurgitation - A finite element modeling study.
    PLoS One. 2019;14:e0223472.
    PubMed     Abstract available


  86. IWANUK N, Wall L, Nolte I, Raue J, et al
    Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly.
    PLoS One. 2019;14:e0223164.
    PubMed     Abstract available


  87. TAKEJI Y, Taniguchi T, Morimoto T, Saito N, et al
    Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.
    PLoS One. 2019;14:e0222979.
    PubMed     Abstract available


  88. SCHAHAB N, Fimmers R, Mahn T, Schaefer C, et al
    Comparative study of pressure (ankle-brachial pressure index) and flow (strain gauge plethysmography and reactive hyperaemia) measurements in diagnosis of peripheral arterial disease in patients with severe aortic stenosis.
    PLoS One. 2019;14:e0220510.
    PubMed     Abstract available


  89. FANG F, Tang J, Zhao Y, He J, et al
    Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low and intermediate risk: A risk specific meta-analysis of randomized controlled trials.
    PLoS One. 2019;14:e0221922.
    PubMed     Abstract available


  90. WANG G, Rao N, Liu D, Jiang H, et al
    Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.
    PLoS One. 2019;14:e0221900.
    PubMed     Abstract available


  91. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Outcome of patients with heart failure after transcatheter aortic valve implantation.
    PLoS One. 2019;14:e0225473.
    PubMed     Abstract available


  92. TANAKA M, Yanagisawa R, Yashima F, Arai T, et al
    Previously implanted mitral surgical prosthesis in patients undergoing transcatheter aortic valve implantation: Procedural outcome and morphologic assessment using multidetector computed tomography.
    PLoS One. 2019;14:e0226512.
    PubMed     Abstract available


  93. DE-MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, De Miguel-Yanes JM, et al
    Trends, characteristics, in-hospital outcomes and mortality in surgical mitral valve replacement among patients with and without COPD in Spain (2001-2015).
    PLoS One. 2019;14:e0221263.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: